Case Report: Medical Management of Acute Severe Ulcerative Colitis

Overview

Journal Gastroenterol Hepatol (N Y)

Specialty Gastroenterology

Date 2024 Feb 26

PMID 38404961

Authors

Sudheer Kumar Vuyyuru

Vipul Jairath

Jurij Hanzel

Christopher Ma

Brian G Feagan

Affiliations

Soon will be listed here.

References

Williams J, Alam M, Alrubaiy L, Arnott I, Clement C, Cohen D . Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial. Lancet Gastroenterol Hepatol. 2016; 1(1):15-24. PMC: 4994668. DOI: 10.1016/S2468-1253(16)30003-6. View

Dinesen L, Walsh A, Nedeljkovic Protic M, Heap G, Cummings F, Warren B . The pattern and outcome of acute severe colitis. J Crohns Colitis. 2010; 4(4):431-7. DOI: 10.1016/j.crohns.2010.02.001. View

Corte C, Fernandopulle N, Catuneanu A, Burger D, Cesarini M, White L . Association between the ulcerative colitis endoscopic index of severity (UCEIS) and outcomes in acute severe ulcerative colitis. J Crohns Colitis. 2015; 9(5):376-81. DOI: 10.1093/ecco-jcc/jjv047. View

Laharie D, Bourreille A, Branche J, Allez M, Bouhnik Y, Filippi J . Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. Lancet. 2012; 380(9857):1909-15. DOI: 10.1016/S0140-6736(12)61084-8. View

Magro F, Gionchetti P, Eliakim R, Ardizzone S, Armuzzi A, Barreiro-de Acosta M . Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. J Crohns Colitis. 2017; 11(6):649-670. DOI: 10.1093/ecco-jcc/jjx008. View

Kohn A, Daperno M, Armuzzi A, Cappello M, Biancone L, Orlando A . Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up. Aliment Pharmacol Ther. 2007; 26(5):747-56. DOI: 10.1111/j.1365-2036.2007.03415.x. View

Grainge M, West J, Card T . Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet. 2010; 375(9715):657-63. DOI: 10.1016/S0140-6736(09)61963-2. View

Lamb C, Kennedy N, Raine T, Hendy P, Smith P, Limdi J . British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019; 68(Suppl 3):s1-s106. PMC: 6872448. DOI: 10.1136/gutjnl-2019-318484. View

Saha S, Panwar R, Kumar A, Pal S, Ahuja V, Dash N . Early colectomy in steroid-refractory acute severe ulcerative colitis improves operative outcome. Int J Colorectal Dis. 2017; 33(1):79-82. DOI: 10.1007/s00384-017-2903-8. View

10.

Ng S, Shi H, Hamidi N, Underwood F, Tang W, Benchimol E . Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017; 390(10114):2769-2778. DOI: 10.1016/S0140-6736(17)32448-0. View

11.

Lindgren S, Flood L, Kilander A, Lofberg R, Persson T, Sjodahl R . Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis. Eur J Gastroenterol Hepatol. 1998; 10(10):831-5. DOI: 10.1097/00042737-199810000-00003. View

12.

Shaffer S, Traboulsi C, Krugliak Cleveland N, Rubin D . Combining Cyclosporine With Ustekinumab in Acute Severe Ulcerative Colitis. ACG Case Rep J. 2021; 8(5):e00604. PMC: 8126549. DOI: 10.14309/crj.0000000000000604. View

13.

Molnar T, Farkas K, Nyari T, Szepes Z, Nagy F, Wittmann T . Response to first intravenous steroid therapy determines the subsequent risk of colectomy in ulcerative colitis patients. J Gastrointestin Liver Dis. 2011; 20(4):359-63. View

14.

Aratari A, Papi C, Clemente V, Moretti A, Luchetti R, Koch M . Colectomy rate in acute severe ulcerative colitis in the infliximab era. Dig Liver Dis. 2008; 40(10):821-6. DOI: 10.1016/j.dld.2008.03.014. View

15.

Bernstein C, Ng S, Lakatos P, Moum B, Loftus Jr E . A review of mortality and surgery in ulcerative colitis: milestones of the seriousness of the disease. Inflamm Bowel Dis. 2013; 19(9):2001-10. DOI: 10.1097/MIB.0b013e318281f3bb. View

16.

Meyers S, Lerer P, Feuer E, Johnson J, Janowitz H . Predicting the outcome of corticoid therapy for acute ulcerative colitis. Results of a prospective, randomized, double-blind clinical trial. J Clin Gastroenterol. 1987; 9(1):50-4. DOI: 10.1097/00004836-198702000-00013. View

17.

Gonzalez-Huix F, Fernandez-Banares F, Esteve-Comas M, Abad-Lacruz A, Cabre E, Acero D . Enteral versus parenteral nutrition as adjunct therapy in acute ulcerative colitis. Am J Gastroenterol. 1993; 88(2):227-32. View

18.

Ollech J, Dwadasi S, Rai V, Peleg N, Normatov I, Israel A . Efficacy and safety of induction therapy with calcineurin inhibitors followed by vedolizumab maintenance in 71 patients with severe steroid-refractory ulcerative colitis. Aliment Pharmacol Ther. 2019; 51(6):637-643. DOI: 10.1111/apt.15616. View

19.

Seow C, Newman A, Irwin S, Steinhart A, Silverberg M, Greenberg G . Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis. Gut. 2009; 59(1):49-54. DOI: 10.1136/gut.2009.183095. View

20.

Nicholls R, Clark D, Kelso L, Crowe A, Knight A, Hodgkins P . Nationwide linkage analysis in Scotland implicates age as the critical overall determinant of mortality in ulcerative colitis. Aliment Pharmacol Ther. 2010; 31(12):1310-21. DOI: 10.1111/j.1365-2036.2010.04302.x. View